Home/Filings/4/0001415889-21-003294
4//SEC Filing

Valdivia Tomas 4

Accession 0001415889-21-003294

CIK 0001671284other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 9:40 PM ET

Size

27.6 KB

Accession

0001415889-21-003294

Insider Transaction Report

Form 4
Period: 2021-02-09
Valdivia Tomas
CHIEF HEALTH & EQUITY OFFICER
Transactions
  • Conversion

    Common Stock

    2021-06-28+11,2864,510,050 total
  • Conversion

    Series A Preferred Stock

    2021-06-2816,6290 total
    Common Stock (11,286 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-02-09125,001800,001 total
    Exercise: $1.09Exp: 2029-04-18Common Stock (125,001 underlying)
  • Exercise/Conversion

    Common Stock

    2021-02-09$1.04/sh+31,251$32,5014,342,515 total
  • Exercise/Conversion

    Common Stock

    2021-02-09$1.09/sh+125,001$135,8394,467,516 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$1.04/sh+6,249$6,4994,473,765 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$1.09/sh+24,999$27,1664,498,764 total
  • Award

    Restricted Stock Units

    2021-06-28+1,050,0001,050,000 total
    Common Stock (1,050,000 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-02-0931,251131,250 total
    Exercise: $1.04Exp: 2028-10-18Common Stock (31,251 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-03-016,249125,001 total
    Exercise: $1.04Exp: 2028-10-18Common Stock (6,249 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-03-0124,999775,002 total
    Exercise: $1.09Exp: 2029-04-18Common Stock (24,999 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    769,560
  • Common Stock

    (indirect: By Spouse)
    769,560
  • Stock Options (Right to Buy)

    Exercise: $2.30Exp: 2030-11-19Common Stock (150,000 underlying)
    150,000
Footnotes (7)
  • [F1]Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
  • [F3]These performance-based restricted stock units ("PSUs") shall vest if the performance conditions are met.
  • [F4]These performance-based restricted stock units ("PSUs") shall vest if the performance conditions are met.
  • [F5]These stock options vest over four years as follows: (a) 25% vested on October 18, 2019 (one year after the grant date), and (b) 1/48 of the original grant amount (300,000) vests in monthly installments for the following three years.
  • [F6]These stock options vest over four years as follows: 1/48 of the original grant amount (300,000) vests in monthly installments over the four year period that began on October 1, 2019.
  • [F7]These stock options vest over four years as follows: (a) 25% vests on December 18, 2021, and (b) 1/48 of the original grant amount vests in monthly installments for the following three years.

Issuer

Bright Health Group Inc.

CIK 0001671284

Entity typeother

Related Parties

1
  • filerCIK 0001867160

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 9:40 PM ET
Size
27.6 KB